Polyunsaturated fatty acid supplementation in young children with autism

Journal of Developmental and Physical Disabilities

Volumn 22, Issue 1, 2010, Pages 1-10

  Johnson, Cynthia R ^a   Handen, Benjamin L ^b   Zimmer, Michelle ^c   Sacco, Kelley ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Alternative treatments; Autism spectrum disorder; Polyunsaturated fatty acid; Preschool children

Indexed keywords

EID: 76149094485     PISSN: 1056263X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10882-009-9152-x     Document Type: Article

References (28)

1. Achenbach, T. M. (2002). Child behavior checklist 1 1/2 -5. Burlington: University of Vermont Department of Psychiatry.
2. Amminger, G. P., Berger, G. E., Schafer, M. R., Klier, C., Friedrich, M. H., & Feucht, M. (2007). Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biological Psychiatry, 61, 551-553.
3. APA. (2000). Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. Washington DC: American Psychiatric Association.
4. Bell, J. G., Sargent, J. R., Tocher, D. R., & Dick, J. R. (2000). Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders? Prostaglandins, Leukotrienes, & Essential Fatty Acids, 63, 21-25.
5. Bell, J. G., MacKinlay, E. E., Dick, J. R., MacDonald, D. J., Boyle, R. M., & Glen, A. C. (2004). Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins, Leukotrienes, & Essential Fatty Acids, 71, 201-204.
6. Bu, B., Ashwood, P., Harvey, D., King, I. B., Water, J. V., & Jin, L. W. (2006). Fatty acid compositions of red blood cell phospholipids in children with autism. Prostaglandins, Leukotrienes, & Essential Fatty Acids, 74, 215-221.
7. Centers for Disease Control and Prevention (2007). Surveillance summaries. MMWR [Electronic Version], 56(No. SS-1). Retrieved May 22, 2007.
8. Fernstrom, J. D. (2000). Can nutrient supplements modify brain function? American Journal of Clinical Nutrition, 71, 1669S-75S.
9. Fombonne, E. (2003). Epidemiological surveys of autism and other pervasive developmental disorders: an update. Journal of Autism & Developmental Disorders, 33, 365-382.
10. Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Davis, J. M., Mischoulon, D., Peet, M., et al. (2006). Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. Journal Clinical Psychiatry, 67, 1954-1967.
11. Hanson, E., Kalish, L., Bunce, E., Curtis, C., McDaniel, S., Ware, J., et al. (2007). Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder. Journal of Autism & Developmental Disorders, 37(4), 628-636.
12. Harrington, J. W., Rosen, L., & Patrick, P. A. (2006). Parental perceptions and use of complementary and alternative medicine practices for children with autistic spectrum disorders in private practice. Developmental and Behavioral Pediatrics, 27, S156-S161.
13. Horrocks, L. A., & Farooqui, A. A. (2004). Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins, Leukotrienes & Essential Fatty Acids, 70, 361-372.
14. Johnson, S. M., & Hollander, E. (2003). Evidence that eicosapentaenoic acid is effective in treating autism. Journal of Clinical Psychiatry, 64, 848-849.
15. Lord, C., Rutter, M., DiLavore, P. C., & Risi, S. (2002). Autism diagnostic observation schedule: A standardized observation of communicative and social behavior. Los Angeles, Western Psychological Services. Developmental disorders.
16. Mullen, E. (1995). Mullen scales of early learning. Circle Pines: American Guidance Service.
17. Newschaffer, C., & Curran, L. (2003). Autism: an emerging public health problem. Public Health Reports, 118, 393-399.
18. Patrick, L., & Salik, R. (2005). The effect of essential fatty acid supplementation on language development and learning skills in autism and Asperger's syndrome. Autism Asperger's Digest, Jan-Feb, 36-37.
19. Politi, P., Cena, H., Comelli, M., Marrone, G., Allegri, C., Emanuele, E., et al. (2008). Behavioral effects of omega-3 fatty acid supplementation in young adults with severe autism: an open label study. Archives of Medical Research, 39, 682-685.
20. Richardson, A. J. (2004). Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins, Leukotrienes, & Essential Fatty Acids, 70, 383-390.
21. Richardson, A. J., & Puri, B. K. (2002). A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Progressive Neuropsychopharmacology Biological Psychiatry, 26, 233-239.
22. Richardson, A. J., & Montgomery, P. (2005). The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics, 115, 1360-1366.
23. Ryan, A. S., & Nelson, E. B. (2008). Assessing the effect of docosahexaenoic acid on cognitive functions in healthy preschool children: a randomized placebo-controlled, double-blind study. Clinical Pediatrics, 47, 355-362.
24. Tapp, J. (2003). Procoder for digital video. Kennedy Center: Vanderbilt University.
25. Uauy, R., Hoffman, D. R., Peirano, P., Birch, D. G., & Birch, E. E. (2001). Essential fatty acids in visual and brain development. Lipids, 36, 885-895.
26. Vancassel, S., Durand, G., Barthelemy, C., Lejeune, B., Martineau, J., Guilloteau, D., et al. (2001). Plasma fatty acid levels in autistic children. Prostaglandins Leukotrienes & Essential Fatty Acids, 65, 1-7.
27. Wainwright, P. E. (2002). Dietary essential fatty acids and brain function: a developmental perspective on mechanisms. Proceeding of the Nutritional Society, 61, 61-69.
28. Wong, H. H. L., & Smith, R. G. (2006). Patterns of complementary and alternative medical therapy use in children diagnosed with autism spectrum disorders. Journal of Autism & Developmental Disorders, 36, 901-909.